Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

Antzeko izenburuak

• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
  nork: Elliott, M, et al.
  Argitaratua: (1994)
• Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
  nork: Maini, R, et al.
  Argitaratua: (1999)
• Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
  nork: Lipsky, P, et al.
  Argitaratua: (2000)
• Infliximab and methotrexate in the treatment of rheumatoid arthritis
  nork: Lipsky, P, et al.
  Argitaratua: (2000)
• Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
  nork: Paleolog, E, et al.
  Argitaratua: (1996)